These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1706927)

  • 41. Lymphokines and cytokines as cancer treatment. Immunotherapy realized.
    Borden EC; Sondel PM
    Cancer; 1990 Feb; 65(3 Suppl):800-14. PubMed ID: 2406003
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interferons and cytokines.
    Luger TA
    Curr Probl Dermatol; 1989; 18():269-76. PubMed ID: 2472932
    [No Abstract]   [Full Text] [Related]  

  • 43. [Recombinant blood hormones in clinical practice].
    von dem Borne AE
    Ned Tijdschr Geneeskd; 1987 Nov; 131(46):2068-72. PubMed ID: 2446154
    [No Abstract]   [Full Text] [Related]  

  • 44. [Bases on timing of combined modality of chemotherapy and immunotherapy].
    Ogura T
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1414-20. PubMed ID: 1697153
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interactions of cytokines in the host.
    Lundholm K
    Acta Chir Scand Suppl; 1989; 549():31-4. PubMed ID: 2648715
    [No Abstract]   [Full Text] [Related]  

  • 46. Biological response modifiers. Interferons, interleukins, and transfer factor.
    Kirkpatrick CH
    Ann Allergy; 1989 Mar; 62(3):170-6. PubMed ID: 2466425
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Design of combination biotherapy studies: future goals and challenges.
    Gilewski TA; Golomb HM
    Semin Oncol; 1990 Feb; 17(1 Suppl 1):3-10; discussion 38-41. PubMed ID: 1689077
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Antitumoral action of interferons and interleukins in combination with radiotherapy. Part I: immunologic basis].
    Herskind C; Fleckenstein K; Lohr J; Li CY; Wenz F; Lohr F
    Strahlenther Onkol; 2004 Apr; 180(4):187-93. PubMed ID: 15057428
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Antitumor immunotherapy].
    Błoński JZ; Warzocha K
    Postepy Hig Med Dosw; 1994; 48(6):701-28. PubMed ID: 7675731
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The development of new immunotherapies for the treatment of cancer using interleukin-2. A review.
    Rosenberg SA
    Ann Surg; 1988 Aug; 208(2):121-35. PubMed ID: 3041925
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cytokines and oncogene activity.
    Black RJ; Friedman RM
    Cancer Surv; 1989; 8(4):725-39. PubMed ID: 2484310
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Symposium on diagnosis and treatment of cancer. Recent progress.
    Jpn J Med; 1988 Feb; 27(1):96-112. PubMed ID: 2452911
    [No Abstract]   [Full Text] [Related]  

  • 53. Principles of biotherapy and its application to the treatment of disseminated renal cancer.
    O'Connor TE; West WH; Marshall GD; Orr DW; Lewis M; Oldham RK
    Semin Surg Oncol; 1988; 4(3):155-60. PubMed ID: 3055159
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interleukins and cancer immunotherapy.
    Yoshimoto T; Morishima N; Okumura M; Chiba Y; Xu M; Mizuguchi J
    Immunotherapy; 2009 Sep; 1(5):825-44. PubMed ID: 20636026
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Review: advances in monoclonal antibody tumour targeting.
    Kosmas C; Linardou H; Epenetos AA
    J Drug Target; 1993; 1(2):81-91. PubMed ID: 8069556
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Induction of anti-tumour lymphocytes in cancer patients after brief exposure to supernatants from cultures of anti-CD3-stimulated allogeneic lymphocytes.
    Baxevanis CN; Tsiatas ML; Cacoullos NT; Spanakos G; Liacos C; Missitzis I; Papadhimitriou SI; Papamichail M
    Br J Cancer; 1997; 76(8):1072-80. PubMed ID: 9376269
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The introduction of interleukins to the world].
    Pelet B; Gautier E
    Rev Med Suisse Romande; 1991 Oct; 111(10):879-83. PubMed ID: 1719599
    [No Abstract]   [Full Text] [Related]  

  • 58. The biological therapy of cancer: a clinical symposium. Dana Point, California, April 8th and 9th, 1988. Proceedings.
    Semin Oncol; 1988 Oct; 15(5 Suppl 5):1-57. PubMed ID: 2461591
    [No Abstract]   [Full Text] [Related]  

  • 59. Immunotherapy.
    James G
    Rev Invest Clin; 1990 Jul; 42 Suppl():22-7. PubMed ID: 19256128
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Cytokines and monoclonal antibodies. Immunologic approaches to tumor therapy].
    Pfreundschuh M
    Fortschr Med; 1986 Dec; 104(47-48):973-6. PubMed ID: 2434398
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.